Wordt geladen...
MicroRNA Signature in Renal Cell Carcinoma
Renal cell carcinoma (RCC) includes 2.2% of all diagnosed cancers and 1.8% of cancer-related mortalities. The available biomarkers or screening methods for RCC suffer from lack of sensitivity or high cost, necessitating identification of novel biomarkers that facilitate early diagnosis of this cance...
Bewaard in:
| Gepubliceerd in: | Front Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734191/ https://ncbi.nlm.nih.gov/pubmed/33330087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.596359 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|